REVHW
REVOLUTION HEALTHCARE -CW28
REVOLUTION HEALTHCARE -CW28 historical holders
total: 1
Arbiter Partners Capital Management REVOLUTION HEALTHCARE -CW28 transactions over time
- Total transactions:
- 2
- New positions:
- 1
- Sold out:
- 1
- Held since:
- 2021 Q3
- Held for:
- 6 quarters
- Latest activity:
- 2023 Q1
Paul Isaac has been an institutional investor in REVOLUTION HEALTHCARE -CW28 (REVHW) since 2021 Q3. According to 2026 Q1 report, Paul Isaac doesn't hold any shares. The fund/company first acquired REVHW in 2021 Q3, initially purchasing 17,780 shares. Since the initial investment, Arbiter Partners Capital Management has made 1 more transaction in this position.
When did Paul Isaac exit their REVHW position?
Paul Isaac no longer holds REVOLUTION HEALTHCARE -CW28 (REVHW). They sold off their entire position in 2023 Q1, closing out an investment that began in 2021 Q3.
When did Paul Isaac first invest in REVHW?
Paul Isaac first invested in REVOLUTION HEALTHCARE -CW28 (REVHW) in 2021 Q3 at the reported quarter-end price of $0.90 per share, acquiring 17,780 shares in their initial purchase.
What is Paul Isaac's average cost basis for REVHW?
Based on historical transaction data, Paul Isaac's estimated cost basis for REVOLUTION HEALTHCARE -CW28 (REVHW) is approximately $0.90 per share. This represents their average reported price* across all buy transactions.
Estimated cost basis*
- Weighted AVG buy price:
- $0.90
- Weighted AVG sell price:
- $0.00
REVHW transactions history by Arbiter Partners Capital Management
2 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2023 Q1
|
0.00%
|
0
|
$0.00
|
|
-100% (-17,780)
|
-0%
|
|
2021 Q3
|
0.01%
|
17,780
|
$0.90
|
$16,000
|
new
|
+0.01%
|
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.